US Joins WHO to Shape Future Flu Vaccines
The United States will attend a WHO meeting to discuss future influenza vaccines. Despite a recent dip in virus sample circulation due to funding issues, shipments are back on track. Maria Van Kerkhove highlighted the importance of the global influenza surveillance network in updating vaccine recommendations biannually.
The United States is set to participate in a World Health Organization meeting at the end of the month. The agenda: deciding the composition of upcoming influenza vaccines.
Maria Van Kerkhove, the WHO's director for epidemic and pandemic preparedness, noted a slight dip in the global circulation of influenza virus samples due to recent funding challenges. However, she assured that shipments have resumed.
The global influenza surveillance and response network, consisting of over 150 laboratories across 130 countries, plays a crucial role in tracking seasonal and zoonotic influenza viruses. This network updates vaccine recommendations every six months.
ALSO READ
-
World Leaders Push for Fairer Pandemic Protection as COVID’s Heavy Toll Drives Action
-
WHO Sets 2027 Southern Hemisphere Flu Vaccine Formula as Viruses Shape Risks
-
WHO Expands Quality Checks for Contraceptives and AI Tools That Help Spot Tuberculosis
-
WHO Brings Global Experts Together to Strengthen Herbal Medicine Quality and Safety
-
El Niño Health Alarm: Rising Heat, Floods and Hunger Put Communities on High Alert
Google News